We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

4 hedge funds and large institutions have $188K invested in Opexa Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

32% less capital invested

Capital invested by funds: $276K → $188K (-$88K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$263

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$160K – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$21K – – –
EEG
3
E.E. Geduld
$6K – – –
UBS Group
4
UBS Group
Switzerland
$1K +$263 +2,388 +29%
SM
5
Sabby Management
Florida
– -$46K -382,765 Closed

OPXAW Hedge Fund Activity: Q4 2015 in Review

4 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q4 2015, worth a combined $188K — down 32% from $276K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of OPXAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $263. The largest seller was Sabby Management, exiting entirely with an estimated $46K sold.

  • 4 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q4 2015, down from 5 in Q3 2015.
  • Funds reported $188K of Opexa Therapeutics, Inc. stock for Q4 2015, down 32% quarter-over-quarter.
  • 0 funds opened new Opexa Therapeutics, Inc. positions in Q4 2015 and 1 closed out, a net change of -1 holder.
  • The largest Opexa Therapeutics, Inc. buyer in Q4 2015 was UBS Group, an estimated $263 added.
  • The largest Opexa Therapeutics, Inc. seller in Q4 2015 was Sabby Management, an estimated $46K sold.

Based on aggregated 13F filings for Q4 2015.